Dietary Supplement Line for Cancer Patients
OncoQOL is a line of dietary supplements and personal care products for cancer patients.
Thorne Research Inc. (Sandpoint, ID) and Helsinn Healthcare SA (Lugano, Switzerland) have partnered to create OncoQOL, a line of dietary supplement and personal care products for cancer patients.
Not intended to cure or treat cancer, each product has been formulated to alleviate common physical symptoms and nutritional deficiencies experienced by cancer patients. Dietary supplements in the portfolio include a complex of branched-chain amino acids and other amino acids to promote weight gain and muscle mass (DazibeQOL) and a wheat germ extract to potentially reduce fatigue (NutraQOL).
The OncoQOL line also includes a DermaQOL line of silicon-free and sulfate-free personal care products, including an aloe cooling spray for irritated skin and a lotion for skin hydration.
OncoQOL products are available through oncologists and other medical professionals in the United States and Canada.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
